Log on / register
Feedback | Support | My details
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW
Malar J 2007, 6:72
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity.
O'Meara WP, Mwangi TW, Williams TN, McKenzie FE, Snow RW, Marsh K
Am J Trop Med Hyg 2008 Aug, 79:185-91
 [PubMed Central] [PubMed] [Related articles]
2.
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ
PLoS Med 2008 Nov 18, 5:e227
 [PubMed Central] [PubMed] [Related articles]
3.
Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area.
Menge DM, Ernst KC, Vulule JM, Zimmerman PA, Guo H, John CC
Am J Trop Med Hyg 2008 Aug, 79:173-7
 [PubMed Central] [PubMed] [Related articles]
4.
The terrain of health policy analysis in low and middle income countries: a review of published literature 1994-2007.
Gilson L, Raphaely N
Health Policy Plan 2008 Sep, 23:294-307
 [PubMed Central] [PubMed] [Related articles]
5.
*** Unable to retrieve article 19018658 ***

 [PubMed Central] [PubMed] [Related articles]
6.
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW
Trop Med Int Health 2008 Jan, 13:99-107
 [PubMed Central] [PubMed] [Related articles]
7.
Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya.
Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW
Trop Med Int Health 2008 Jun, 13:784-7
 [PubMed Central] [PubMed] [Related articles]
8.
Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya.
Gikandi PW, Noor AM, Gitonga CW, Ajanga AA, Snow RW
Trop Med Int Health 2008 Feb, 13:208-17
 [PubMed Central] [PubMed] [Related articles]
9.
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Oesterholt MJ, Alifrangis M, Sutherland CJ, Omar SA, Sawa P, Howitt C, Gouagna LC, Sauerwein RW, Bousema T
PLoS One 2009, 4:e4364
 [PubMed Central] [PubMed] [Related articles]
10.
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR
Malar J 2008, 7:262
 [PubMed Central] [PubMed] [Related articles]
11.
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
Njogu J, Akhwale W, Hamer DH, Zurovac D
East Afr Med J 2008 May, 85:213-21
 [PubMed Central] [PubMed] [Related articles]
12.
The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
Gitonga CW, Amin AA, Ajanga A, Kangwana BB, Noor AM, Snow RW
Trop Med Int Health 2008 Apr, 13:487-94
 [PubMed Central] [PubMed] [Related articles]
13.
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.
Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW
Am J Trop Med Hyg 2009 May, 80:737-8
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 8 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.